411
Views
12
CrossRef citations to date
0
Altmetric
Review

Postpartum infection treatments: a review

&
Pages 1297-1313 | Published online: 02 Mar 2005

Bibliography

  • CUNNINGHAM FG, MACDONALD PC, GANT NF et al: Postpartum Endometritis. In: Williams Obstetrics, (26h edn) Appleton & Lange, Stanford, Connecticut, USA (1997):547–567.
  • YONEKURA ML: Risk factors for postcesarean endomyometritis. Am. Med. (1985) 78:178–187.
  • PIPER JM, NEWTON ER, BERKUS MD, PEAIRS WA: Meconium: a marker for peripartum infection. Obstet. Gynecel (1998) 91:741–745.
  • GIBBS RS, LISTWA HM, READ JA: The effect of internal fetal monitoring on maternal infection following caesarean section. Obstet. Gynecel (1976) 48:653–658.
  • DUFF P: Pathophysiology and management of postcesarean endomyometritis. Obstet. Gynecel (1986) 67:269–276.
  • MYLES TD, GOOCH J, SANTOLAYA J: Obesity as an independent risk factor for infectious morbidity in patients who undergo caesarean delivery. Obstet. Gynecel (2002) 100:959–964.
  • WAGER GP, MARTIN DH, KOUTSKY L et al.: Puerperal infectious morbidity: relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am.' Obstet. Gynecel (1980) 138:1028–1033.
  • SWARTZ WH, GROLLE K: The use of prophylactic antibiotics in caesarean section. A review of the literature. Repred. Med. (1981) 26:595–609.
  • ROSENE K, ESCHENBACH DA, TOMPKINS L et al.: Polymicrobial early postpartum endometritis with facultatively anaerobic and anaerobic bacteria, genital mycoplasmas and Chlamydia trachomatis. .1. Infect. Dis. (1986) 153:1028.
  • DUFF P: Prophylactic antibiotics for caesarean delivery: a simple cost-effective strategy for prevention of post-operative morbidity. Jim. .1 Obstet. Gynecel (1987) 157:794–798.
  • HAWRYLSHYN PA, BERENSTEIN P, PAPSIN FR: Risk factors associated with infection following caesarean section. Am. J. Obstet. Gynecel (1981) 139:94–98.
  • POLK BF: Antimicrobial prophylaxis to prevent mixed bacterial infection. .1. Antimicreb. Chemether: (1981) 8:115–129.
  • LARSEN B: Vaginal flora in health and disease. Clio. Obstet. Gynecel (1993) 36:107–121.
  • SHERMAN D, LURIE S, BETZER M, PINHASI Y, ARIELI S, BOLDUR I: Uterine flora at caesarean and its relationship to postpartum endometritis. Obstet. Gynecel (1999) 94:787–791.
  • NEWTON ER, PRIHODA TJ, GIBBS RS: A clinical and microbiologic analysis of risk factors for puerperal endometritis. Obstet. Gynecel (1990) 75:402–406
  • MINKOFF H: Prematurity: infection as an etiologic factor. Obstet. Gynecel (1983) 62:137–144.
  • •This is the first time that infection was related to prematurity.
  • KURKI T, SIVONEN A, RENKONEN O-V, SAVIA E, YLIKORKALA 0: Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet. Gynecel (1992) 80:173–177.
  • MINKOFF H, GRUNEBAUM AN, SCHWARTZ RH: Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am. Obstet. Gynecel (1984) 150:965–972.
  • HAY P, LAM ONT R, TAYLOR-ROBINSON D, MORGAN J, ISON C, PEARSON J: Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Br. Med. J. (1994) 308:295–298.
  • UGWUMADU A, MANYONDA I, REID F, HAY PH: Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet (2003) 361:983–88.
  • •The results of this study shows a benefit in treating asymptomatic pregnant women to prevent preterm birth.
  • GARDNER HL, DAMPEER TK, DUKES CD: The prevalence of vaginitis. Am. J. Obstet. Gynecel (1957) 73:1080–1087.
  • HILL LH, RUPERALIA H, EMBIL JA:Nonspecific vaginitis and other genital infections in three clinic populations. Sex. Transm. Dis. (1983) 10:114–118.
  • SPIEGEL CA, AMSEL R, ESCHEMBACH DJ, SCHOENKNECHT F, HOLMES KK: Anaerobic bacteria in nonspecific vaginitis. N Engl. Med. (1980) 303:601–607.
  • THOMASSON JL, SCHRECKENBERGER PC, SPELLACY WN et al.: Clinical and microbiological characterization of patients with nonspecific vaginosis having motile curved anaerobic rods. Infect. Dis. (1984) 149:801–805.
  • AMSEL R, TOTTEN PA, SPIEGEL CA et al.: Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological associations. Am.j Med. (1983) 74:14–22.
  • NUGENT RP, KROHN MA, HILLIER SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. j. Clin. Microbiol (1991) 29:297–301.
  • •For standardising Gram stain interpretation.
  • CHAIM W, KARPAS Z, LORBER A: New technology for diagnosis of bacterial vaginosis. Eur. I Obstet. Cynecol Reprod. Biol. (2003) (In Press).
  • •Shows a great simplification for BV diagnosis.
  • LAMONT RE DUNCAN SLB, MANDAL D, and BASSETT P: Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet. Cynecol (2003) 101:516–22.
  • •The results of this study shows a benefit in treating asymptomatic pregnant women to prevent preterm birth.
  • LIVINGSTON JC, LLATA E, RINEHART E et al.: Gentamicin and clindamycin therapy in postpartum endometritis: the efficacy of daily dosing versus dosing every 8 hours. Am. J. Obstet. Cynecol (2003) 188:149–152.
  • FARO S: Postpartum Endometritis. In: Infectious Diseases in Women, Faro S, Soper D (Eds.), WB Saunders Company (2001) 14:181–193.
  • KORN AP, BOLAN G, PADIAN N, OHM-SMITH M, SCHACHTER J, LANDERS DV: Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet. Cynecol (1995) 85:387–390.
  • KEKKI M, KURKI T, PAAVONEN J, RUTANEN EM: Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet (1999) 353:1494.
  • WANG D, WANG Z, DI H: The relationship between fetal fibronectin, bacterial vaginosis and chorioammionitis. Zhonghua Fu Chan Ke Za Zhi (1999) 34:399–400.
  • YOON BH, ROMERO R, MOON JB, OH SY et al.: The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin. Am. J. Obstet. Cynecol (2001) 185:1137–1142.
  • WATTS DH, KROHN MA, HILLIER SL, ESCHENBACH DA: Bacterial vaginosis as a risk factor for post-caesarean endometriris. Obstet. Cynecol (1990) 75:52–58.
  • GOLDENBERG RL, THOM E, MOAWAD AH, JOHNSON F, ROBERTS J, CARITIS SN: The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection: NICHD Maternal Fetal Medicine Units Network. Obstet. Cynecol (1996) 87:656–660.
  • KURKINEN-RATY M, RUOKONEN A, VUOPALA S et al: Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. Br. I Obstet. Cynaecol (2001) 108:875–881.
  • PITT C, SANCHEZ-RAMOS L, KAUNITZ AM: Adjunctive intravaginal Metronidazole for the prevention of postcesarean endometritis: A randomised controlled trial. Obstet. Cynecol (2001) 98:745–750.
  • DONOWITZ LG, WENZEL RP: Endometritis following caesarean section: a controlled study of the increase duration of hospital stay and direct cost of hospitalisation. Am. I Obstet. Cynecol (1980) 137:467–469.
  • CHAMBERS HF, PETRI WA Jr: Antimicrobial agents. In: The Pharmacological Bash of Therapeutics, 111h edn, Goodman Gillman A, Hardman JG, Limbird L E (Eds), McGraw-Hill (2001) 44–47:1143–1272.
  • HENDERSON E, LOVE EJ: Incidence of hospital acquired infections associated with caesarean section., 1 Hosp. Infect (1995) 29:245–255.
  • FRENCH LM, SMAILL FM: Antibiotic regimens for endometritis after delivery. (Cochrane review). In: The Cochrane Library (2002) Issue 4, Oxford: Update Software. Gives a very reliable overview on PPE treatment.
  • MITRA AG, WHITTEN MK, LAURENT SL, ANDERSON WE: A randomised prospective study comparing once daily gentamicin versus thrice daily gentamicin in the treatment of puerperial infection. Am. Obstet. Cynecol (1997) 177:786–792.
  • BRIGGS GG, AMBROSE P, NAGEOTTE MP: Gentamicin dosing in postpartum women with endometritis. Am.j Obstet. Cynecol (1989) 160:309–313.
  • GOLDENBERG RL, KLEBANOFF M, CAREY JC, MACPHERSON C. Metronidazole treatment of women with a positive fetal fibronectin test result. Am. Obstet. Cynecol (2001) 185:485–486.
  • AKALIN HE: The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections. Int. I Antimicrob. Agents (1999) 12 (Suppl. 1):515–520; Discussion: S26–S27.
  • GALL S, KOUKOL DH: Ampicillin/Sulbactam versus clindamycin/gentamicin in the treatment of postpartum endometritis. I Reprod. Med. (1996) 41:575–580.
  • KEKKI M, KURKI T, PELKONEN J, KURKINEN-RATY M, CACCIATORE B, PAAVONEN J: Vaginal Clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: A randomised, controlled trial. Obstet. Cynecol (2001) 97:643–648.
  • GIBBS RS, ST CLAIR PJ, CASTANEDA YS: Bacteriologic effects of antibiotic prophylaxis in high-risk caesarean section. Obstet. Cynecol (1981) 57:277–282.
  • MARTENS MG, FARO S, MACCATO M, HAMMILL HA: Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis. Am.j Obstet. Cynecol (1991) 164:1383–1386.
  • HILLIER S, WATTS DH, LEE ME ESCHENBACH DA: Aetiology and treatment of post-caesarean section endometritis after cephalosporin prophylaxis. I Reprod. Med. (1990) 35:322–328.
  • NEWTON ER, WALLACE PA: Effect of prophylactic antibiotic in endometrial flora in women with post-caesarean endometritis. Obstet. Cynecul (1998) 92:262–268.
  • DUFF P: Maternal and Perinatal infection. In: Obstetrics: Normal and Problem Pregnancies, (4th edn)Gabbe SG, Niebyl JR, Simpson JL (Eds.), Churchill Livingstone (2002) Chapter 40:1303–1305.
  • CHAIM W, BASHIRI A, BAR-DAVID J, SHOHAM-VARDI I, MAZOR M: Prevalence and clinical significance of postpartum endometritis and wound infection. Infect. Dis. Obstet. Cynecul (2000) 8:77–82.
  • MOLLER BR, AHRONS S, LAUREN J et al.: Pelvic infection after elective abortion associated with Chlamydia trachomatis. Obstet. Cynecul (1982) 59:210–214.
  • FRENCH RA, COLE C: An 'enigmatic' cause of back pain following regional anesthesia for caesarean section: septic pelvic thrombophlebitis. Anaesth. Intensive Care (1999) 27:209–212.
  • DUFF P, GIBBS RS: Pelvic vein thrombophlebitis: diagnostic dilemma and therapeutic challenge. Obstet. query]. Surv. (1983) 38:365–369.
  • DERRICK FC, TURNER WR, HOUSE EE et al: Evidence of right ovarianvein syndrome in pregnant females. Obstet. query]. (1970) 35:37–41.
  • DUNN LJ, VAN VOORHIS LW: Enigmatic fever and pelvic thrombophlebitis. N Engl. .1. Med. (1967) 276:262–266.
  • JOSEY WE, COOK CC: Septic pelvic thrombophlebitis. Obstet. query]. (1970) 35:891–896.
  • BROWN CE, STETTLER RW, TWICKLER D, CUNNINGHAM FG: Puerperal septic thrombophlebitis: incidence and response to heparin therapy. Am. J. Obstet. query]. (1999) 181:143–148.
  • BROWN TK, MUNSICK RA: Puerperal ovarian vein thrombophlebitis: a syndrome. Am. .1 aster query]. (1970) 109:263–268.
  • HIBBARD LT, SNYDER EN, MCVANN RM: Subgluteal and retropsoal infection in obstetrical practice. Obstet. query]. (1972) 39:238–241.
  • HIRSH J: Low-molecular-weight heparinfor the treatment of venous thromboembolism. Am. Heart j (1998) 135:S336–S342.
  • DUNCAN JT, WALKER J: Staphylococcusaureus in the milk of nursing mothers and the alimentary canal of their infants. Hyg. (1942) 42:474–479.
  • NIEBYL JR, SPENCE MR, PARMLEY TH: Sporadic (nonepidemic) puerperal mastitis. J. Reprod. Med. (1978) 20:97–100.
  • RAVENHOLT RT, WRIGHT P, MULHERN M: Epidemiology and prevention of nursery-derived staphylococcal disease. N Engl. J. Med. (1957) 257:789–795.
  • SHERMAN AJ, PORTER HC, EISENBERG GM: Puerperal breast abscess: II. Epidemiologic factors in hospital-acquired infection. Obstet. query]. (1979) 8:81–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.